Recently, it was revealed in two relevant and specific engineered pancreatic cancer mouse models made homozygous-null for transcriptionally active p73 (TAp73) that this p53 family member is a critical regulator of the TGF-β pathway. This evidence concerns the gene TGFB1 and familial pancreatic carcinoma.